ES2156143T3 - Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas. - Google Patents

Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.

Info

Publication number
ES2156143T3
ES2156143T3 ES94403038T ES94403038T ES2156143T3 ES 2156143 T3 ES2156143 T3 ES 2156143T3 ES 94403038 T ES94403038 T ES 94403038T ES 94403038 T ES94403038 T ES 94403038T ES 2156143 T3 ES2156143 T3 ES 2156143T3
Authority
ES
Spain
Prior art keywords
polyaminated
ligands
diagnostic
therapeutic applications
preparation procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94403038T
Other languages
English (en)
Inventor
Dominique Meyer
Olivier Rousseaux
Michel Schaeffer
Christian Simonot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet SA
Original Assignee
Guerbet SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet SA filed Critical Guerbet SA
Application granted granted Critical
Publication of ES2156143T3 publication Critical patent/ES2156143T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DE POLI(AMINOACIDOS) QUELADORES DE IONES METALICOS PARAMAGNETICOS 3 ATOMOS AL MENOS DE NITROGEO DONANTES LLEVAN SUSTITUYENTES,IDENTICOS O DIFERENTES DE FORMULA CH(R1)-X EN LA QUE X REPRESENTA CO2R, CONRBRC O P(RD)O2H, Y RA, RB, RC IDENTICOS O DIFERENTES REPRESENTAN H O (C1-C8)ALKILO, EVENTUALMENTE HIDROXILADO; RD REPRESENTA OH, (C1-C8)ALKILO O (C1-C8)ALKOXI; Y R1 REPRESENTA UN GRUPO HIDROFILO DE MASA MOLECULAR SUPERIOR A 200, QUE COMPRENDE AL MENOS 3 ATOMOS DE OXIGENO QUE SE ENTIENDEN COMO 3 DE LOS GRUPOS X SON FUNCIONES ACIDAS, EVENTUALMENTE SALIFICADAS.
ES94403038T 1993-12-30 1994-12-27 Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas. Expired - Lifetime ES2156143T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9315933 1993-12-30

Publications (1)

Publication Number Publication Date
ES2156143T3 true ES2156143T3 (es) 2001-06-16

Family

ID=9454621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94403038T Expired - Lifetime ES2156143T3 (es) 1993-12-30 1994-12-27 Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.

Country Status (19)

Country Link
US (2) US5712389A (es)
EP (1) EP0661279B1 (es)
JP (1) JP3862299B2 (es)
KR (1) KR100328575B1 (es)
CN (1) CN1056162C (es)
AT (1) ATE199550T1 (es)
AU (1) AU687120B2 (es)
CA (1) CA2139374C (es)
CZ (1) CZ289751B6 (es)
DE (1) DE69426811T2 (es)
DK (1) DK0661279T3 (es)
ES (1) ES2156143T3 (es)
FI (1) FI113171B (es)
GR (1) GR3035913T3 (es)
IL (1) IL112175A (es)
NO (1) NO306721B1 (es)
NZ (1) NZ270289A (es)
PT (1) PT661279E (es)
ZA (1) ZA9410382B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2156143T3 (es) * 1993-12-30 2001-06-16 Guerbet Sa Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.
ZA958789B (en) * 1994-10-21 1996-05-29 Nihon Mediphysics Co Ltd Diagnostic imaging agent
TW319763B (es) 1995-02-01 1997-11-11 Epix Medical Inc
US6713045B1 (en) 1995-06-02 2004-03-30 Research Corporation Technologies, Inc. Targeted magnetic resonance imaging agents for the detection of physiological processes
US6770261B2 (en) 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
IT1283218B1 (it) * 1996-03-08 1998-04-16 Bracco Spa Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
EP1032430A2 (en) 1997-11-17 2000-09-06 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
FR2772025B1 (fr) * 1997-12-10 2000-03-03 Guerbet Sa Chelates metalliques de macrocycles polyaminocarboxyliques et leur application a l'imagerie par resonance magnetique
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
US20040170562A1 (en) * 1999-12-01 2004-09-02 Uzgiris Egidijus Edward Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging
US6685915B2 (en) * 1999-12-01 2004-02-03 General Electric Company Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
AU2001276956A1 (en) 2000-07-17 2002-01-30 California Institute Of Technology Macrocyclic mri contrast agents
US7029655B2 (en) 2000-10-04 2006-04-18 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
EP1390079A2 (en) 2000-11-20 2004-02-25 Board of Regents University of Texas System Paramagnetic metal ion-based macrocylic contrast agents
US20030050452A1 (en) * 2000-12-26 2003-03-13 Yuji Hashiguchi Process for producing metal complex of aminooligosaccharide derivative
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
DE10135356C1 (de) * 2001-07-20 2003-04-17 Schering Ag Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
FR2829493B1 (fr) * 2001-09-10 2005-08-05 Commissariat Energie Atomique Composes thermosensibles presentant un point de trouble, utilisables comme extractants pour la separation de metaux en solution aqueuse
EP1369134A1 (en) 2002-06-05 2003-12-10 Bracco Imaging S.p.A. New agents for magnetic imaging method
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
US20040022857A1 (en) * 2002-07-31 2004-02-05 Uzgiris Egidijus E. Synthesis of highly conjugated polymers
FR2856063B1 (fr) * 2003-06-13 2005-10-07 Air Liquide Procede de preparation du cis-8b-methyldecahydro-2a,4a,6a, 8a-tetraazacyclopenta[fg]acenaphthylene,ou du cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, du cyclene, et de cyclenes fonctionnalises
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
FR2857967B1 (fr) * 2003-07-25 2015-04-24 Centre Nat Rech Scient Complexes de lanthanide, leur preparation et leurs utilisations
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
CN101090739B (zh) * 2004-07-02 2012-10-10 伯拉考成像股份公司 磁共振成像中用作高弛豫造影剂配体的1，4-二（羧甲基）氨基-6-甲基-全氢-1，4-二氮杂*（aazta)衍生物
CA2581639C (en) 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
WO2006121889A2 (en) * 2005-05-06 2006-11-16 Epix Pharmaceuticals, Inc. Chemical exchange saturation transfer contrast agents
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US8926945B2 (en) 2005-10-07 2015-01-06 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
EP1964846A1 (en) * 2007-02-27 2008-09-03 Bracco Imaging, S.P.A. Process for the preparation of contrast agents
FR2914303A1 (fr) * 2007-03-28 2008-10-03 Guerbet Sa Composes pour le diagnostic de l'apoptose.
FR2914304B1 (fr) 2007-03-28 2012-11-16 Guerbet Sa Composes pour le diagnostic de maladies liees a l'expression de vcam.
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
JP5735791B2 (ja) * 2010-12-07 2015-06-17 住友化学株式会社 金属錯体を含む素子
CN104583712B (zh) 2012-08-15 2017-12-01 诺威量测设备股份有限公司 用于原位测量的光学计量
US20160287726A1 (en) * 2015-04-06 2016-10-06 The Trustees Of The University Of Pennsylvania Cationic contrast agents and methods of using the same
US10918742B2 (en) 2016-03-25 2021-02-16 Nanoprobes, Inc. Iodine-based particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
EP0529645B1 (en) * 1986-09-05 1996-10-23 GANSOW, Otto A. Process for the preparation of backbone polysubstituted chelates
ATE120457T1 (de) * 1988-06-24 1995-04-15 Dow Chemical Co Macrocyclische bifunktionelle chelatbildner, komplexe davon und ihre konjugierten antikörper.
WO1990009379A1 (en) * 1989-02-10 1990-08-23 Celltech Limited Aza-macrocycles and processes for their preparation
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5141740A (en) * 1990-11-21 1992-08-25 Mallinckrodt Medical, Inc. Complexes and compositions for magnetic resonance imaging and usage methods
JPH0565930A (ja) * 1991-09-06 1993-03-19 Kayaba Ind Co Ltd フロントフオーク
EP0565930A1 (en) * 1992-03-27 1993-10-20 Nihon Medi-Physics Co., Ltd. Tetraazacyclododecane tetraacetic acid derivatives and the use thereof as diagnostic agents
ES2156143T3 (es) * 1993-12-30 2001-06-16 Guerbet Sa Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.

Also Published As

Publication number Publication date
NO306721B1 (no) 1999-12-13
AU687120B2 (en) 1998-02-19
PT661279E (pt) 2001-06-29
FI113171B (fi) 2004-03-15
CN1056162C (zh) 2000-09-06
CN1110974A (zh) 1995-11-01
CA2139374A1 (en) 1995-07-01
FI946157L (fi) 1995-07-01
KR950017976A (ko) 1995-07-22
DE69426811T2 (de) 2001-09-13
JP3862299B2 (ja) 2006-12-27
US5919432A (en) 1999-07-06
ZA9410382B (en) 1996-06-29
KR100328575B1 (ko) 2002-11-16
EP0661279B1 (fr) 2001-03-07
DK0661279T3 (da) 2001-07-16
NO945069D0 (no) 1994-12-29
IL112175A (en) 1999-08-17
CA2139374C (en) 2007-11-20
US5712389A (en) 1998-01-27
IL112175A0 (en) 1995-03-15
ATE199550T1 (de) 2001-03-15
GR3035913T3 (en) 2001-08-31
NO945069L (no) 1995-07-03
JPH07224050A (ja) 1995-08-22
AU8178094A (en) 1995-07-06
CZ289751B6 (cs) 2002-03-13
DE69426811D1 (de) 2001-04-12
NZ270289A (en) 1996-05-28
EP0661279A1 (fr) 1995-07-05
CZ332294A3 (en) 1995-07-12
FI946157A0 (fi) 1994-12-29

Similar Documents

Publication Publication Date Title
ES2156143T3 (es) Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
DE69825618D1 (de) Biologisch-abbaubare anionische polymere, die sich von der aminosäure l-tyrosin herleiten
DE59009093D1 (de) Kaskadenpolymer-gebundene Komplexbildner, deren Komplexe und Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel.
BR9408151A (pt) Processos de hidrocianação de precursor de catalisador
ES2060002T3 (es) Compuestos formadores de quelatos para la complejacion de isotopos radiactivos, sus complejos con metales, asi como su utilizacion en diagnostico y terapia.
FR2412582A1 (fr) Composition a mouler polymere thermoplastique presentant une stabilite hydrolytique amelioree
ATE9354T1 (de) Die blutkoagulation aktivierende produkte und verfahren zu deren herstellung.
HU895608D0 (en) Process for the preparation of chelates containing ortho ligating functional group and complexes thereof
ATE250641T1 (de) Ungeordnete siloxan-copolymer, verfahren zur herstellung und diesen copolymer enthaltende zusammensetzung
DE59009817D1 (de) Neuartige monomerbausteine aus hydroxyfettsäuren zur herstellung von kunststoffen.
ATE85058T1 (de) Jodhaltige polymere mit skeletten von dextran, verfahren zu ihrer herstellung und ihre verwendungen als kontrastmittel.
NO175313C (no) Joderte polymerer og deres anvendelse
ES2030449T3 (es) Procedimiento para la preparacion de polimeros acrilicos imidizados.
DE59010838D1 (de) Glycosyl-Etoposid-Prodrugs, Verfahren zu ihrer Herstellung und ihre Anwendung in Kombination mit funktionalisierten tumorspezifischen Enzym-Konjugaten
ES2109418T3 (es) Procedimiento para la preparacion de polimeros a base de monoxido de carbono y olefinas.
ES8300735A1 (es) Un procedimiento para la preparacion de derivados de acidos fenil-alcanoicos.
ES2038665T3 (es) Procedimiento de sintesis de penems.
DE3854266D1 (de) Verfahren zur Modifizierung eines Molekularsiebes.
DE3573121D1 (en) Diacylderivatives of glycerylphosphorylcholine having therapeutical activity, a process for their preparation and related pharmaceutical compositions
ATE92056T1 (de) Verfahren zur herstellung von 5-chlor-3chlorsulfonyl-2-thiophencarbonsaeureestern.
WO1997000127A3 (en) Catalyst composition and process for the preparation of copolymers of carbon monoxide and an olefinically unsaturated compound
MY106165A (en) Catalyst compositions and polymerization process, hexakisphosphines and hexahalo compounds
ATE105293T1 (de) Phosphortrilactame und verfahren zu deren herstellung.
ATE181561T1 (de) Verfahren zur herstellung von copolymeren aus kohlenmonoxid und mindestens einer verbindung mit olefinischer ungesättigtheit

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661279

Country of ref document: ES